| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T648 |
0-177 |
Sentence |
denotes |
The collaborative effort of the researchers of Rocky Mountain Laboratories and Oxford University is designing a chimpanzee adenovirus-vectored vaccine to counter COVID-19 (180). |
| T649 |
178-302 |
Sentence |
denotes |
The Coalition for Epidemic Preparedness Innovations (CEPI) has initiated three programs to design SARS-CoV-2 vaccines (181). |
| T650 |
303-426 |
Sentence |
denotes |
CEPI has a collaborative project with Inovio for designing a MERS-CoV DNA vaccine that could potentiate effective immunity. |
| T651 |
427-635 |
Sentence |
denotes |
CEPI and the University of Queensland are designing a molecular clamp vaccine platform for MERS-CoV and other pathogens, which could assist in the easier identification of antigens by the immune system (181). |
| T652 |
636-877 |
Sentence |
denotes |
CEPI has also funded Moderna to develop a vaccine for COVID-19 in partnership with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) (182). |
| T653 |
878-1049 |
Sentence |
denotes |
By employing mRNA vaccine platform technology, a vaccine candidate expressing SARS-CoV-2 spike protein is likely to go through clinical testing in the coming months (180). |
| T654 |
1050-1208 |
Sentence |
denotes |
On 16 March 2020, Jennifer Haller became the first person outside China to receive an experimental vaccine, developed by Moderna, against this pandemic virus. |
| T655 |
1209-1349 |
Sentence |
denotes |
Moderna, along with China’s CanSino Biologics, became the first research group to launch small clinical trials of vaccines against COVID-19. |
| T656 |
1350-1443 |
Sentence |
denotes |
Their study is evaluating the vaccine’s safety and ability to trigger immune responses (296). |
